-
good news
Time of Update: 2023-03-02
In order to further support technological innovation and encourage technology-based SMEs to increase investment in research and development, the Ministry of Finance, the State Administration of Taxation, and the Ministry of Science and Technology jointly issued an announcement a few days ago to further increase the pre-tax deduction ratio of research and development expenses for technology-based SMEs .
-
Cell Discovery: "Lock Up" Omicron! Chinese scientists have developed bispecific antibodies that can target all new crown variants to prevent and treat both
Time of Update: 2023-02-01
1038/s41421-022-00509-9 Recently, Chinese scientists published a paper in the journal Cell Discovery [1], proposing a new bispecific antibody that can effectively bind to 16 new coronavirus variants tested, including the widely circulating BA.
-
R&D investment continues to increase, and the modernization of Chinese medicine is accelerating
Time of Update: 2023-02-01
In addition, in recent years, Yiling Pharmaceutical is also making full use of the methods and means of modern science and technology to continuously increase investment in scientific research and leapfrog development of innovative Chinese medicine drugs on the basis of inheriting and carrying forward the advantages and characteristics of traditional Chinese medicine.
-
Prediction of prognosis, monitoring of recurrence, application and breakthrough of ctDNA in the diagnosis and treatment of gastric cancer
Time of Update: 2023-01-06
ctDNA can detect efficacy and prognosis in anti-HER2 therapy for advanced gastric cancerClinical evidence showed that ctDNA NGS detection was performed on blood samples of 40 patients with advanced gastric cancer receiving anti-HER2 therapy at baseline, after treatment and at the time of disease progression, and by analyzing the abundance of TP53 and HER2 mutations, 40% of patients could predict disease progression before CT evaluation, and the trend of disease progression could be detected on average 38.
-
Prediction of prognosis, monitoring of recurrence, application and breakthrough of ctDNA in the diagnosis and treatment of gastric cancer
Time of Update: 2023-01-06
ctDNA can detect efficacy and prognosis in anti-HER2 therapy for advanced gastric cancerClinical evidence showed that ctDNA NGS detection was performed on blood samples of 40 patients with advanced gastric cancer receiving anti-HER2 therapy at baseline, after treatment and at the time of disease progression, and by analyzing the abundance of TP53 and HER2 mutations, 40% of patients could predict disease progression before CT evaluation, and the trend of disease progression could be detected on average 38.
-
Technical guidance for sugarcane production to cope with drought and rainfall in 2022
Time of Update: 2023-01-04
In order to minimize the loss of disaster and ensure the stable supply of raw cane, the National Agricultural Technology Extension Service Center, together with the sugar expert guidance group of the Ministry of Agriculture and Rural Affairs, put forward the following technical guidance for coping with drought and little rain, and guided local governments to do a good job in the post-production management of sugarcane and cane planting in winter and spring.
-
200 billion subsidized interest loans Domestic scientific instrument manufacturers ushered in a good opportunity for development
Time of Update: 2023-01-04
Original: 200 billion discounted interest loans Domestic scientific instrument manufacturers ushered in a good opportunity for development 【Chemical Machinery and Equipment Network Industry News】On October 14, Haineng Future Technology Group Co.
-
The water turnover equation predicts the daily water demand of the human body
Time of Update: 2022-12-30
Is it really scientific to drink eight glasses of water (about 2 liters) a day for good health? Recently, a study published in the journal Science has subverted people's previous perception of drinkin
-
Wood will deploy the first lidar on a Scottish floating turbine
Time of Update: 2022-12-27
”(This article first published cable network: /, please indicate the source for reprinting)Wood has announced that it will deploy the first scanning lidar (light detection and ranging) device on two floating wind turbines at Hywind Scottish Pilot Park, located 25km off Peterhead Coast in Aberdeenshire, Scotland.
-
Heda Solar produces 4 series of solar photovoltaic ceramic tiles
Time of Update: 2022-11-19
Photovoltaic ceramic tiles Solar photovoltaic ceramic tile has 8W, 20W, 24W, 50W, 150T (150W), 250P (250W) and other power, which can meet different grades and customer needs, divided into four grade series.
-
Issue 30, 2014 - International project for petrochemical wastewater treatment started
Time of Update: 2022-11-13
At the launch ceremony, Professor Li Xiangkai of Lanzhou University introduced the implementation of the project.
At the launch ceremony, Professor Li Xiangkai of Lanzhou University introduced the implementation of the project.
At the launch ceremony, Professor Li Xiangkai of Lanzhou University introduced the implementation of the project.
-
Issue 6/2015 - Breakthrough in carbonation utilization of industrial solid waste
Time of Update: 2022-11-13
(Mountain) The Ministry of Science and Technology recently released news that the "863" Plan Bulk Industrial Solid Waste Comprehensive Treatment and Resource Key Technology Major Project Office organized experts from Peking University, University of Science and Technology Beijing and Wuhan University to conduct on-site inspections of the separation and extraction of calcium and magnesium components of steel slag and the preparation technology of nano calcium carbonate undertaken by the Institute of Process Engineering of the Chinese Academy of Sciences.
-
J Immunother Cancer Shanghai Institute of Materia Medica, found that PD-L1/TLR7 dual-targeted nanobody conjugate drugs can reshape the tumor immune microenvironment
Time of Update: 2022-11-04
gov/36253000/ PD-L1/TLR7 dual-targeted nanoantibody conjugates reshape the tumor immune microenvironment (Contributing department: Gong Likun Research Group) Tumor immunotherapy represented by immune checkpoint inhibitors has changed the pattern of cancer treatment, PD-1/PD-L1 blockade therapy has made breakthroughs in the treatment of a variety of tumors, but it has problems such as low response rate and drug resistance recurrence, and it is found that new PD treatment strategies to improve efficacy are urgent problems to be solved.
-
For use in Fahrenheit macroglobulinemia, Baekje Zebutinib is recommended by NICE in the UK
Time of Update: 2022-10-02
Today, the good news is once again coming from Baekje that the UK's National Institute for Health and Clinical Excellence (NICE), the UK's health technology assessment body, has released a final assessment document recommending Beyote ® Ze (zebutinib) for the treatment of adult patients with Fahrenheit macroglobulinemia (WM) who have previously received at least one treatment and are suitable for a combination of benzdamustine-rituximab (BR).
-
BeiGene R&D is expected to exceed 10 billion, what is the confidence
Time of Update: 2022-09-21
Source: Minnet BeiGene currently has 16 new drugs that have been commercialized 3 self-developed products, but only 8 products have sales, half of the products need to burn money for research and development, follow-up listing still needs time, sales costs, which means that the current commercial realization of sales obviously can not run the R & D investment funds, but the first half of the R & D expenses are still 860 million yuan more than last year.
